MIR4692

Across TCGA pan-cancer cohorts, MIR4692 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR4692’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR4692 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4692 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

BRCA, THCA, and LIHC are the cancer types where MIR4692 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4692 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.281	.001	4	view →
THCA	All	II,III,IV	+0.274	.011	4	view →
LIHC	All	All	+0.181	.005	2	view →
STAD	Female	III,IV	−1.035	.033	1	view →
KICH	All	II,III,IV	+0.207	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MIR4692–BRCA

Open the BRCA breakdown →